Buy AB-001 Cannabinoid Online

Description
Buy AB-001 Cannabinoid Online or 1-pentyl-3-(1-adamantoyl)indole is a designer drug that was found as an ingredient in synthetic cannabis smoking blends in Ireland in 2010 and Hungary and Germany in 2011. It is unclear who AB-001 was originally developed by, but it is structurally related to compounds such as AM-1248 and its corresponding 1-(tetrahydropyran-4-ylmethyl) analogue, which are known to be potent cannabinoid agonists with moderate to high selectivity for CB2 over CB1.

Description AB-001: Full chemical name AB-001: 1-pentyl-3-(adamant-1-oyl)indole Other names AB-001: 1-pentyl-3-(1-adamantoyl)indole, AB-001 CAS number of substance AB-001: 1345973-49-0 Physical properties AB-001: White powder finely ground Formula AB-001: C24H31N Molar mass of the substance AB-001: 349,508 g/mol Purity of the preparation AB-001: 98% and above

AB-001 or 1-pentyl-3-indole is a designer drug that was found as an ingredient in synthetic cannabis smoking blend

Buy AB-001 Experience Online or 1-pentyl-3-(1-adamantoyl)indole is a designer drug that was found as an ingredient in synthetic cannabis smoking blends in Ireland in 2010 and Hungary and Germany in 2011. It is unclear who AB-001 was originally developed by, but it is structurally related to compounds such as AM-1248 and its corresponding 1-(tetrahydropyran-4-ylmethyl) analogue, which are known to be potent cannabinoid agonists with moderate to high selectivity for CB2 over CB1.

Buy AB-001 Cannabinoid Online

Description AB-001: Full chemical name AB-001: 1-pentyl-3-(adamant-1-oyl)indole Other names AB-001: 1-pentyl-3-(1-adamantoyl)indole, AB-001 CAS number of substance AB-001: 1345973-49-0 Physical properties AB-001:

AB-001 or 1-pentyl-3-indole is a designer drug that was found as an ingredient in synthetic cannabis smoking blends

Buy AB-001 Experience Online or 1-pentyl-3-(1-adamantoyl)indole is a designer drug that was found as an ingredient in synthetic cannabis smoking blends in Ireland in 2010 and Hungary and Germany in 2011. It is unclear who AB-001 was originally developed by, but it is structurally related to compounds such as AM-1248 and its corresponding 1-(tetrahydropyran-4-ylmethyl) analogue, which are known to be potent cannabinoid agonists with moderate to high selectivity for CB2 over CB1.